Skip to main content
OpenTrials
Completed

NCT Number: NCT02145845

Pilot Safety Study of Injectable SIS for Critical Limb Ischemia

This study is intended to collect safety and effectiveness data on the Cook Injectable Small Intestinal Submucosa (SIS)

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of critical limb ischemia
  • Rutherford 4-5 or Leriche-Fontaine IIIB
  • Patient unable to be treated by endovascular or surgical means

Exclusion criteria

  • Patient's age is <21
  • Patient is pregnant or breast-feeding (or is planning to become pregnant within the next year)
  • Patient has had a previous surgery, within 30 days of the study procedure
  • Patient has any planned surgical or interventional procedure within 30 days after the study procedure
  • Patient has a life expectancy less than 1 year
  • Patient has a known allergy to pigs or pig products, or has a religious or cultural objection to the use of pig tissue
  • Additional restrictions as specified in the Clinical Investigation Plan

Treatment and study plan

Injectable SIS

Device

Injectable SIS

Primary outcomes

  1. Frequency and types of adverse events after treatment with the Cook Injectable SIS

    Time frame: 180 days

Sponsors and collaborators

Lead sponsor

Cook Group Incorporated

Industry

Registry information

Official study title

Pilot Safety Study of Injectable Small Intestine Submucosa (SIS) for Critical Limb Ischemia

Acronym: CLIC

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
May 23, 2014
Registry last updated
Dec 21, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.